Kinepolis Group NV/€KIN

1D1W1MYTD1Y5YMAX

About Kinepolis Group NV

Kinepolis Group NV is a Belgian company operating in the film exhibition industry. It specializes in managing multiplex cinema complexes and offers a wide range of film-related entertainment services. Established in 1997, the company was founded through a merger of two family businesses, Bert and Claeys, which already had a history in film exhibition. Kinepolis's headquarters are located in Ghent, Belgium, and the company has expanded its footprint across several European countries and Canada. It differentiates itself through innovative cinema designs, advanced technology integration, and a focus on enhancing customer experience, allowing it to maintain a competitive position in the market.
Ticker
€KIN
Sector
Consumer Discretionary
Primary listing
BSE
Employees
5,000
Headquarters
Brussels, Belgium
Website
www.kinepolis.com

KIN Metrics

BasicAdvanced
€1.3B
22.01
€2.23
0.41
€0.46
0.93%

Bulls say / Bears say

Kinepolis delivered a strong first half: admissions rose 33.8% to 19.1 million, revenue increased 32.6% to €341.8 million, and profit rose to €25.2 million from €7.0 million a year earlier. This shows the recovery is reaching both volume and the bottom line. (Kinepolis Group)
Premium seating, projection and other upgrades are increasing the value of each customer: adjusted EBITDA after leases per visitor rose from €3.38 to €4.24 in the first half. If this pricing and mix improvement persists, earnings can grow faster than attendance. (MarketScreener)
The US expansion offers a relatively low-cost route to scale and property value. The Showcase deal adds 13 cinemas and 164 screens for an enterprise value of $30 million, with six owned sites and about $90 million of 2025 revenue across the acquired circuit. (Euronext)
The rebound remains exposed to the release calendar: Kinepolis said 2025 admissions fell 5.8%, while the first half of 2026 was helped by a dense run of major films. It also provided no concrete full-year outlook, so earnings visibility remains limited. (MarketScreener, MarketScreener)
The US roll-up brings execution risk as well as growth. Showcase generated about $90 million of revenue but only roughly break-even theatre-level cash flow in 2025, and it must be integrated alongside the recently acquired Emagine circuit. (Euronext, MarketScreener)
The margin of safety has narrowed after the rally. LSEG data reported that the shares were trading at 17 times forward earnings, up from 12 times three months earlier, while net financial debt excluding leases stood at €287.2 million at the end of 2025. (Stockopedia, MarketScreener)
Data summarised monthly by Lightyear AI. Last updated on 16 Sept 2026.

Funds containing KIN

AllEURGBPUSD
Funds
Fund name
Fund size
€KIN weighting
Xtrackers MSCI Europe Small Cap€DX2J
€3.2B0.05%
Xtrackers MSCI Europe Small Cap£XXSC
£2.8B0.05%
iShares MSCI World Small Cap$WSML
$9B0.01%
iShares MSCI World Small Cap€IUSN
€7.8B0.01%
iShares MSCI World Small Cap£WLDS
£6.7B0.01%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.